From: 1 <[email protected]> Sent: Wednesday, December 5, 2018 12:14 PM To: [email protected] Subject: Re: https://www.nature.com/articles/s41467-018-07214-w <https://www.nature.com/article=/s41467-018-07214-w> On Mon, De= 3, 2018 at 8:13 AM Church, George c, wrote: I enjoyed the conversation too. =AO Thanks for asking about the 27 cos. Most of these are either very=young newcos (15 in 2018) or I had minor/diluted shares. Also payback in biotech is slower than most investments. Even though=my Harvard lab is very frugal (reducing costs by 10 million-fold), and mos= our 90 employees get paid less than $60K per year, we still have many goo= ideas that don't get implemented. Also, last week I learned that our largest and longest grant won't be =enewable for the very odd reason that we have been too successful in peer-review. A few members of Congress '=ight' be looking for examples of 'Center of Excellence' =eams that are getting money year after year. (Sounds like Harrison Be=geron). <https://en.wikipedia.org/wiki/Harrison_Bergeron> The administrators are afraid that one su=cessful lab could endanger many other grants (or even their whole program)= They aren't even that sure about the Congressional concern rumor, but this is still enough to derail my lab renewal. Thanks again.</=> --George From= "jeffrey E.&=uot; <[email protected] <mailto:[email protected]» Date: Monday, December 3 2018 at 5:01 AM To: George Church lots of fun yesterday , thx for coming=C2 . I was surprised to hear that with 27 cos formed =ou were stil concerned about money? . would you ikke the share=the details of the situation? to see if i can be helpful please no=e The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for EFTA_R1_01808809 EFTA02612489